Haleon (HLN) announced the appointment of Richard Manso as US Chief Marketing Officer. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon’s evolution into a more agile, consumer-centric organization. Manso will lead Haleon’s integrated US marketing organization, advancing how the company connects with consumers in the moments where health decisions actually happen. He will work across categories and global teams to integrate data, technology and human insight, strengthening Haleon’s ability to deliver more personalized, transparent and relevant health experiences.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon’s New Sensitivity Toothpaste Trial in China: What Investors Should Watch
- Haleon: Structural Growth Potential and Attractive Valuation Support Buy Rating Despite Near-Term Demand Softness
- Haleon price target raised to 512 GBp from 510 GBp at Berenberg
- Haleon price target raised to 440 GBp from 420 GBp at Morgan Stanley
- Haleon: Solid Underlying Growth and Margin Strength Support Buy Rating Despite Near-Term Cold & Flu Headwinds